Gavi plans to deploy $600 million in restored United States funding to expand malaria vaccination programs and other immunization efforts. The capital injection follows a year-long freeze and addresses a projected $1.9 billion budget shortfall for the 2026–2030 period. Restoring these funds supports preventive campaigns for diseases like cholera and accelerates a transition to mercury-free formulas requested by U.S. health officials.

Closing the Malaria Funding Gap